| A Study of Immunohistochemical Evaluation of bcl-2 Protein and p53 Protein Expression in Epithelial Ovaria Cancers. |
|
Sang Joon Choi, Young Ho Kim, Gyung Chul Rhu, Sei Jun Han, Chang Hun Song, Hyuk Jung, Sung Chul Lim |
1Department of Obstetrics and Gynecology, College of Medicine, Chosun University, Kwangju, Korea.
2Department of Pathology, College of Medicine, Chosun University, Kwangju, Korea. |
|
|
| Abstract |
|
Bcl-2 and p53, two proteins, have implicated in apoptosis and among them p53 is known as adverse prognostic factor in a number of tumors. But it is variable in different tissues whether bcl-2 expression and its role are related in the prognosis. The present study was aimed to find the role of bcl-2 and p53 in prognosis of epithelial ovarian cancer. We examined 32 epithelial ovarian cancer specimens of different histologic types and stages by immunohistochemical staining. Bcl-2 protein expression was found in 11/32 epithelial ovarian cancers and it was related in survival(p=0.0038) and p53 accumulation was found in 17/32 epithelial ovarian cancers but it was not rrelated in survival(p=0.0717). But bcl-2 expression and p53 accumulation were not related to the FIGO stages(p>0.05). The analysis of the postoperative course of 32 patients showed that survival depended on the FIGO stages(p=0.001 2) and the histologic type(p=0.009). However, bcl-2 immunohistochemistry identified a subgroup of patients with p53 and bcl-2 positive carcinomas who had not a statistically better outcome(p=0.082) than patients with p53 positive and bcl-2 negative carcinomas. Thus our observations point to different molecular alterations possibly underlying phenotypic diversity of ovarian carcinomas and provide clues for a better understanding of tumor progression in these neoplasms. |
| Key Words:
Epithelial ovarian cancer, bcl-2, p53 |
|
Full text via DOI
Download Citation
